Projects funded by the NCN
Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptors plus iNOS inhibition or AMPK activation
2021/41/B/NZ7/03757
Keywords:
cannabinoid CB1 receptor iNOS inhibitor AMPK activator pulmonary hypertension
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Białymstoku
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 13
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 2 115 480 PLN
Project start date (Y-m-d): 2022-01-10
Project end date (Y-m-d): 2026-01-09
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.